Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1984 Jan;55(1):140–148.

Low T lymphocyte responsiveness to Mycobacterium leprae antigens in association with HLA-DR3.

W van Eden, B G Elferink, R R de Vries, D L Leiker, J J van Rood
PMCID: PMC1535784  PMID: 6362932

Abstract

The type of leprosy which develops after infection with Mycobacterium leprae is influenced by the presence or absence of HLA-DR3, as has been demonstrated in an ethnic group originating from Surinam. In the present study we investigated in this same ethnic group the role of HLA-DR, and of HLA-DR3 in particular, in monocyte-T cell interactions during leprosy specific proliferative responses in vitro. HLA-DR3 heterozygous T cells from tuberculoid leprosy patients were cultured with antigen and either HLA-DR3 positive or HLA-DR3 negative homozygous HLA-DR compatible allogeneic monocytes as antigen presenting cells (APCs). T cell proliferative responses with DR3 homozygous monocytes as APCs, were observed to be decreased as compared to T cell proliferative responses with DR3 negative homozygous monocytes as APCs. Furthermore, although the leprosy specific monocyte-T cell interactions were shown to be restricted for HLA-DR, in the anti-MLW-1 response HLA-DR3 appeared to function as a restricting element poorly or not at all. These observations may imply, that an in vitro correlate has been found for an (HLA associated) genetic control of leprosy in vivo.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergholtz B. O., Thorsby E. Macrophage-dependent response of immune human T lymphocytes to PPD in vitro. Influence of HLA-D histocompatibility. Scand J Immunol. 1977;6(8):779–786. doi: 10.1111/j.1365-3083.1977.tb02151.x. [DOI] [PubMed] [Google Scholar]
  2. Bright S., Munro A. J. Studies on the role of HLA-DR in macrophage-T cell interactions. Tissue Antigens. 1981 Oct;18(4):217–231. doi: 10.1111/j.1399-0039.1981.tb01385.x. [DOI] [PubMed] [Google Scholar]
  3. Closs O., Reitan L. J., Negassi K., Harboe M., Belehu A. In vitro stimulation of lymphocytes in leprosy patients, healthy contacts of leprosy patients, and subjects not exposed to leprosy. Comparison of an antigen fraction prepared from Mycobacterium leprae and tuberculin-purified protein derivative. Scand J Immunol. 1982 Aug;16(2):103–115. doi: 10.1111/j.1365-3083.1982.tb00704.x. [DOI] [PubMed] [Google Scholar]
  4. De Boer M., Reijneke R., Van de Griend R. J., Loos J. A., Roos D. Large-scale purification and cryopreservation of human monocytes. J Immunol Methods. 1981;43(2):225–239. doi: 10.1016/0022-1759(81)90027-2. [DOI] [PubMed] [Google Scholar]
  5. Godal T. Immunological aspects of leprosy--present status. Prog Allergy. 1978;25:211–242. [PubMed] [Google Scholar]
  6. Rosenthal A. S., Shevach E. M. Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes. J Exp Med. 1973 Nov 1;138(5):1194–1212. doi: 10.1084/jem.138.5.1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Termijtelen A., van Leeuwen A., van Rood J. J. HLA-linked lymphocyte activating determinants. Immunol Rev. 1982;66:79–101. doi: 10.1111/j.1600-065x.1982.tb00435.x. [DOI] [PubMed] [Google Scholar]
  8. Van Eden W., Elferink D., De Vries R. R. An approach to study in vitro the expression of HLA-encoded genetic factors predisposing to tuberculoid leprosy. J Immunogenet. 1983 Apr;10(2):107–114. doi: 10.1111/j.1744-313x.1983.tb01023.x. [DOI] [PubMed] [Google Scholar]
  9. de Vries R. R., van Eden W., van Rood J. J. HLA-linked control of the course of M. leprae infections. Lepr Rev. 1981 Dec;52 (Suppl 1):109–119. [PubMed] [Google Scholar]
  10. van Eden W., de Vries R. R., D'Amaro J., Schreuder I., Leiker D. L., van Rood J. J. HLA-DR-associated genetic control of the type of leprosy in a population from surinam. Hum Immunol. 1982 Jul;4(4):343–350. doi: 10.1016/0198-8859(82)90007-6. [DOI] [PubMed] [Google Scholar]
  11. van Eden W., de Vries R. R., Stanford J. L., Rook G. A. HLA-DR3 associated genetic control of response to multiple skin tests with new tuberculins. Clin Exp Immunol. 1983 May;52(2):287–292. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES